MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.
   Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Wang J, Zou K, Feng X, et al. Downregulation of NMI promotes tumour growth and predicts poor prognosis in human lung adenocarcinomas. Mol Cancer. 2017;16:158.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454.
   PubMed Web of Science ®Google Scholar
• Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002;347:2141–2148.
   PubMed Web of Science ®Google Scholar
• Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5:58–68.
   PubMed Web of Science ®Google Scholar
• Sano H, Kuroki Y. The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol Immunol. 2005;42:279–287.
   PubMed Web of Science ®Google Scholar
• Wu H, Kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111:1589–1602.
   PubMed Web of Science ®Google Scholar
• Kudo K, Sano H, Takahashi H, et al. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immunol. 2004;172:7592–7602.
   PubMed Web of Science ®Google Scholar
• Schurch D, Ospina OL, Cruz A, et al. Combined and independent action of proteins SP-B and SP-C in the surface behavior and mechanical stability of pulmonary surfactant films. Biophys J. 2010;99:3290–3299.
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Takahashi M, Ariki S, et al. Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling. Oncogene. 2015;34:4285–4286.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Kato M, Shukuya T, et al. Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study. BMC Cancer. 2017;17:302.
   PubMed Web of Science ®Google Scholar
• Umeda Y, Hasegawa Y, Otsuka M, et al. Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients. Oncogene. 2017;36:6432–6445.
   PubMed Web of Science ®Google Scholar
• Kaur A, Riaz MS, Murugaiah V, et al. A recombinant fragment of human surfactant protein D induces apoptosis in pancreatic cancer cell lines via Fas-mediated pathway. Front Immunol. 2018;9:1126.
   PubMed Web of Science ®Google Scholar
• Kaur A, Riaz MS, Singh SK, et al. Human surfactant protein D suppresses epithelial-to-mesenchymal transition in pancreatic cancer cells by downregulating TGF-beta. Front Immunol. 2018;9:1844.
   PubMed Web of Science ®Google Scholar
• Jiang F, Caraway NP, Nebiyou Bekele B, et al. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer. Clin Cancer Res. 2005;11:5417–5424.
   PubMed Web of Science ®Google Scholar
• Kim JG, Kim MJ, Choi WJ, et al. Wnt3A induces GSK-3β phosphorylation and β-Catenin accumulation through RhoA/ROCK. J Cell Physiol. 2017;232:1104–1113.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi A, Goto H, Kuramoto T, et al. Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumour-associated macrophages. Am J Pathol. 2013;182:1843–1853.
   PubMed Web of Science ®Google Scholar
• Sin DD, Tammemagi CM, Lam S, et al. Pro-surfactant protein B as a biomarker for lung cancer prediction. J Clin Oncol. 2013;31:4536–4543.
   Google Scholar
• Li R, Todd NW, Qiu Q, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res. 2007;13:482–487.
   PubMed Web of Science ®Google Scholar
• Shirjang S, Mansoori B, Asghari S, et al. MicroRNAs in cancer cell death pathways: apoptosis and necroptosis. Free Radic Biol Med. 2019;139:1–15.
   PubMed Web of Science ®Google Scholar
• Pinweha P, Rattanapornsompong K, Charoensawan V, et al. MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers. Comput Struct Biotechnol J. 2016;14:223–233.
   PubMed Web of Science ®Google Scholar
• Lv Y, Chen S, Wu J, et al. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3beta pathway. Artif Cells Nanomed Biotechnol. 2019;47:2083–2090.
   PubMed Web of Science ®Google Scholar
• Sheedy P, Medarova Z. The fundamental role of miR-10b in metastatic cancer. Am J Cancer Res. 2018;8:1674–1688.
   PubMed Web of Science ®Google Scholar
• Xue M, Shi D, Xu G, et al. The long noncoding RNA linc00858 promotes progress of lung cancer through miR-3182/MMP2 axis. Artif Cells Nanomed Biotechnol. 2019;47:2091–2097.
   PubMed Web of Science ®Google Scholar
• Cui X, Yi Q, Jing X, et al. Mining prognostic significance of MEG3 in human breast cancer using bioinformatics analysis. Cell Physiol Biochem. 2018;50:41–51.
   PubMedGoogle Scholar
• Pan JH, Zhou H, Cooper L, et al. LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers. Front Immunol. 2019;10:6.
   PubMed Web of Science ®Google Scholar
• Cai L, Lin S, Girard L, et al. LCE: an open web portal to explore gene expression and clinical associations in lung cancer. Oncogene. 2019;38:2551–2564.
   PubMed Web of Science ®Google Scholar
• Sun H, Ni SJ, Ye M, et al. Hedgehog interacting protein 1 is a prognostic marker and suppresses cell metastasis in gastric cancer. J Cancer. 2018;9:4642–4649.
   PubMed Web of Science ®Google Scholar
• Thapa S, Chetry M, Huang K, et al. Significance of aquaporins’ expression in the prognosis of gastric cancer. Biosci Rep. 2018;38:BSR20171687
   PubMed Web of Science ®Google Scholar
• Yan Y, Xu Z, Hu X, et al. SNCA is a functionally low-expressed gene in lung adenocarcinoma. Genes (Basel). 2018;9:16.
   PubMed Web of Science ®Google Scholar
• Wu G, Yu W, Zhang M, et al. MicroRNA-145-3p suppresses proliferation and promotes apotosis and autophagy of osteosarcoma cell by targeting HDAC4. Artif Cells Nanomed Biotechnol. 2018;46:579–586.
   PubMed Web of Science ®Google Scholar
• Chou PH, Liao WC, Tsai KW, et al. TACCO, a database connecting transcriptome alterations, pathway alterations and clinical outcomes in cancers. Sci Rep. 2019;9:3877.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang H, Qin Y, et al. MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumour progression of prostate carcinoma. Ann Transl Med. 2019;7:141.
   PubMed Web of Science ®Google Scholar
• Wang J, Song C, Tang H, et al. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Breast Cancer Res. 2017;19:72.
   PubMed Web of Science ®Google Scholar